Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hyperplane on the transaction. Brazil-based Nubank (NU) announced it has agreed to acquire Hyperplane, a data intelligence company from Silicon...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Mobile Health on the transaction, while Paul Hastings and Bass, Berry & Sims advised H.I.G. Growth Partners. H.I.G. Growth Partners...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised TravelPerk on the transaction, and Bradley Arant Boult Cummings advised AmTrav. TravelPerk announced its acquisition of the industry-leading United States...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. is advising Yext on the transaction, and Latham & Watkins is advising Hearsay Systems. Yext, Inc. (NYSE: YEXT), the leading...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Armis on the transaction, and Wilson Sonsini Goodrich & Rosati advised Silk Security. Armis, the asset intelligence cybersecurity company, announced that it has...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is representing WeBull Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati is representing SK Growth Opportunities Corporation. Webull Corporation (“Webull” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Hyperexponential in the transaction. Osborne Clarke advised Highland Europe. Hyperexponential announced the closing of its $73 million Series B funding round led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BibliU on the transaction. BibliU announced the acquisition of Texas Book Company, a privately held company in Texas. This acquisition...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Humu on the transaction. Perceptyx announced it has acquired Humu, a technology company that uses science-based ‘nudges’ to influence positive behavior...
You must be a Standard 1 Year member to access this content.
